Abstract Objective Visceral fat accumulation is an underlying component of the metabolic syndrome (MetS
Introduction
The metabolic syndrome is a major target for the prevention of atherosclerotic cardiovascular diseases (1, 2) . Visceral fat accumulation is associated with the development of metabolic disorders including glucose intolerance, dyslipide-
T a b l e 1 . Cl i n i c a l Ch a r a c t e r i s t i c s o f t h e S t u d y S u b j e c t s
lated to the metabolic syndrome (1, 8) .
The adipose-specific endocrine factor, adiponectin, exhibits anti-atherogenic, anti-diabetic and anti-inflammatory properties (9, 10) , but the plasma level of this endocrine factor is low in obese subjects (11) . Hypoadiponectinemia is associated with coronary artery disease, type 2 diabetes, essential hypertension, and metabolic syndrome (12) (13) (14) (15) and seems to be a key molecule in the development of cardiovascular diseases in metabolic syndrome.
The association between hyperuricemia, visceral fat and hypoadiponectinemia has not been well investigated in the general population. The aim of the present study was to examine the relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese employed men. (20) , systolic and diastolic blood pressure (21) , serum triglyceride (20, 21) and γGTP (22) , and negatively with adiponectin. Figure 1 shows scattergrams which demonstrate correlation between serum uric acid levels and visceral fat area (Fig. 1a) or serum adiponectin concentration (Fig. 1b) (24) (25) (26) (27) . Hyperuricemia is also frequently accompanied by the metabolic syndrome including obesity, dyslipidemia, elevated blood pressure and insulin resistance (28) (29) (30) . In global and Japanese guidelines for the metabolic syndrome, hyperuricemia is stated as a metabolic disorder related to the metabolic syndrome (1, 8) .
Materials and Methods

Subjects
T a b l e 2 . Co r r e l a t i o n Co e f f i c i e n t s o f Re l a t i o n s h i p s b e t we e n S e r u m Ur i c Ac i d L e v e l s a n d Va r i o u s P a r a me t e r s o f t h e Me t a b o l i c S y n d r o me Ca l c u l a t e d f r o m
Definition of hyperuricemia and metabolic syndrome
Hyperuricemia was defined as serum uric acid !7 mg/dL according to the 2002 guidelines of the Japanese Society of Gout and Nucleic Acid Metabolism (18). Metabolic syndrome was defined according to the recent report of the National Health and Nutrition Survey (2005) (19).
Statistical analysis
v s c a t e g o r y 2 b y Kr u s k a l -Wa l l i s t e s t a n d Ga me s -Ho we l l t e s t .
T a b l e 3 . S t e p wi s e Mu l t i p l e Re g r e s s i o n wi t h S e r u m Ur i c Ac i d L e v e l s a s t h e De p e n d e n t Va r i a b l e , Ca l c u l a t e d f r o m Da t a o f 1 , 5 2 0 J a p a n e s e Me n lated positively with creatinine (Cr)
In the present study, serum uric acid levels were significantly associated with visceral fat accumulation. Numerous epidemiological studies have shown a positive correlation between body weight and serum uric acid levels (31, 32) . Recently, it was reported in a cross-sectional study that serum uric acid levels were associated with visceral fat accumulation (33) . Compared with previous studies, the follow-ing features are unique to the present study; 1) inclusion of a large number (1, 520 (34, 35) , and that hyperinsulinemia associated with visceral fat obesity may reduce urinary urate excretion in parallel with a decrease in urinary sodium excretion (36) . Recently, several studies reported that hyperuricemia is an independent risk factor for atherosclerotic cardiovascular diseases (37, 38) , and experimental studies demonstrated that uric acid per se could cause dysfunction of vascular endothelial cells, proliferation of smooth muscle cells and stimulation of production of C-reactive protein from these cells (39, 40 
